TGFB1 and cancer: In many cancer cells, the TGF-β signalling is disrupted [68], and therefore, TGF-β is no longer able to downregulate the cell cycle, causing a simultaneous proliferation of both cancer and surrounding stromal cells in the setting of an immunosuppressive and pro-angiogenic microenvironment [69].